.png)
.png)
Precision medicine in chronic diseases: increasing probability of R&D success with causal AI
Join the Causal AI precision medicine company, PrecisionLife, for a deep dive into how Causal AI is increasing probability of success throughout biopharma innovation, from concept to the clinic.
Not knowing which patients will respond to which drugs is a major cause of drug development risk and healthcare inefficiency. PrecisionLife has completely reimagined how to analyze multi-modal patient data to enable drug developers to better understand and use causal biology - increasing the probability of success in discovery, development, and product launch.
This event is a unique opportunity for drug developers to hear from PrecisionLife about the application of Causal AI to inform and de-risk each stage of biophrama R&D.
Join to learn more about novel mechanism-based biomarkers and how they are being used to design and de-risk clinical trials, identify valuable label extension opportunities, and build precision medicine-ready programs.
The event is designed for professionals in the biopharma and healthcare industry, particularly those working in senior strategic, business development and licensing, translational research, and clinical development positions. Free - first come, first served
Not knowing which patients will respond to which drugs is a major cause of drug development risk and healthcare inefficiency. PrecisionLife has completely reimagined how to analyze multi-modal patient data to enable drug developers to better understand and use causal biology - increasing the probability of success in discovery, development, and product launch.
This event is a unique opportunity for drug developers to hear from PrecisionLife about the application of Causal AI to inform and de-risk each stage of biophrama R&D.
Join to learn more about novel mechanism-based biomarkers and how they are being used to design and de-risk clinical trials, identify valuable label extension opportunities, and build precision medicine-ready programs.
The event is designed for professionals in the biopharma and healthcare industry, particularly those working in senior strategic, business development and licensing, translational research, and clinical development positions. Free - first come, first served